In contrast, C1 and Pevonedistat exerted minimal inhibitory effects on TKO and mOB cells (Fig. 5A, B), suggesting that these drugs are selective for SKP2-expressing tumor cells. The gene discussed is SKP2; the disease is neoplasm.